BeOne Medicines ONC
NASDAQ ONC
$369.06 -5.02 (-1.34%)
At close: Oct 16, 2026 · 4:00 PM EDT

BeOne Medicines (ONC) Gains from Sales and Divestitures (2015 - 2018)

Updated

BeOne Medicines (ONC) posted Gains from Sales and Divestitures of -$125,000 for Q4 2018.

Analysis

BeOne Medicines (ONC) Gains from Sales and Divestitures (2015 - 2018) Analysis & Trends

For FY2018, BeOne Medicines' Gains from Sales and Divestitures came in at -$126,000.

  • In prior years, BeOne Medicines' Gains from Sales and Divestitures was -$85,000 in FY2017, -$5,000 in FY2015 and -$53,000 in FY2014.
  • The Q4 2018 figure stands as the highest quarterly Gains from Sales and Divestitures since Q1 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 BeOne Medicines 41.22 Bn 22.75 Bn 1.53 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -125,000.00
Mar 31, 2017 -7,000.00
Dec 31, 2015 -2,000.00
Sep 30, 2015 -1,000.00
API Access

BeOne Medicines Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ONC&period=max&api_key=YOUR_API_KEY